11 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease ... Pneumocystis pneumonia (PCP ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease ... Pneumocystis pneumonia (PCP ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Pulmonary Infections ... 200: CMV, HSV Mycobacterial ... Diseases Fellows ... #HIVAIDS #workup ... #diagnosis #evaluation
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Mycobacteria ... Tuberculosis Diagnosis ... staining, NAA (PCR ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Mycobacteria ... Tuberculosis Diagnosis ... staining, NAA (PCR ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Disseminated MAC Disease ... disseminated MAC disease ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Recommendations for Treating Mycobacterium ... and molecular diagnostic ... #LTBI #Mycobacterium ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
worsening of that disease ... pericarditis, peritoneal disease ... organizing PNA • Mycobacterium ... leukoencephalopathy (PML ... #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Skin exam for infection ... Ischemic heart disease ... Intraabdominal - Orthopedic ... medical and surgical management ... stratification #diagnosis
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Effusion Lymphoma (PEL ... KS treatment PEL ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology